Use of Vibrio cholerae vaccine in an outbreak in Guinea

New England Journal of Medicine

Volumn 370, Issue 22, 2014, Pages 2111-2120

  Luquero, Francisco J ^a   Grout, Lise ^a,d   Ciglenecki, Iza ^d   Sakoba, Keita ^b,e   Traore, Bala ^f   Heile, Melat ^d   Diallo, Alpha Amadou ^e   Itama, Christian ^g   Page, Anne Laure ^a   Quilici, Marie Laure ^c   Mengel, Martin A ^b   Eiros, Jose Maria ^h   Serafini, Micaela ^d   Legros, Dominique ^d   Grais, Rebecca F ^a  

^a EPICENTRE   (France)

^b Agency of Preventive Medicine   (France)

^c INSTITUT PASTEUR   (France)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

^e National Coordination Cell in the Fight against Ebola   (Guinea)

^f Direction Prefectorale de la Sante   (Guinea)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; SHANCHOL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; EPIDEMIC; FEMALE; GUINEA; HUMAN; INFECTION PREVENTION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHORT COURSE THERAPY; TREATMENT OUTCOME; VACCINATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHOLERA; CHOLERA VACCINES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE OUTBREAKS; DRUG STORAGE; FEMALE; GUINEA; HUMANS; LOGISTIC MODELS; MALE; POPULATION SURVEILLANCE; VIBRIO CHOLERAE; YOUNG ADULT;

EID: 84901816578     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1312680     Document Type: Article

References (29)

1. Ali M, Lopez AL, You YA, et al. The global burden of cholera. Bull World Health Organ 2012;90:209A-218A.
2. Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 2010;85:117-28.
3. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet 2012;379:2466-76.
4. Lucas MES, Deen JL, von Seidlein L, et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 2005;352:757-67. (Pubitemid 40271170)
5. Clemens JD, Sack DA, Harris JR, et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 1986;2:124-7. (Pubitemid 16098257)
6. Sur D, Lopez AL, Kanungo S, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet 2009;374:1694-702. [Erratum, Lancet 2010;376:1392.]
7. Sur D, Kanungo S, Sah B, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis 2011;5(10):e1289.
8. Bhattacharya SK, Sur D, Ali M, et al. 5 Year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2013;13:1050-6. [Erratum, Lancet Infect Dis 2013;13:1011.]
9. Shin S, Desai SN, Sah BK, Clemens JD. Oral vaccines against cholera. Clin Infect Dis 2011;52:1343-9.
10. Pastor M, Pedraz JL, Esquisabel A. The state-of-the-art of approved and underdevelopment cholera vaccines. Vaccine 2013;31:4069-78.
11. Martin S, Costa A, Perea W. Stockpiling oral cholera vaccine. Bull World Health Organ 2012;90:714.
12. Luquero FJ, Grout L, Ciglenecki I, et al. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012. PLoS Negl Trop Dis 2013;7(10):e2465.
13. Médecins Sans Frontières. Cholera guidelines. Paris: Médecins San Frontières, 2004.
14. First steps for managing an outbreak of acute diarrhoea. Geneva: World Health Organization, 2010 (http://www.who.int/cholera/publications/firststeps/ en/index.html).
15. Cholera outbreak: assessing the outbreak response and improving preparedness. Geneva: World Health Organization, 2010 (http://www.who.int/ cholera/publications/OutbreakAssessment/en/index.html).
16. Ciglenecki I, Sakoba K, Luquero FJ, et al. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS Med 2013;10(9):e1001512.
17. 1. In: Laboratory methods for the diagnosis of cholera vibrio and other vibrios. Paris: Institut Pasteur, 1992:59-82.
18. Hoshino K, Yamasaki S, Mukhopadhyay AK, et al. Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Med Microbiol 1998;20:201-7. (Pubitemid 28172698)
19. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010;362:289-98.
20. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14.
21. Holmgren J, Svennerholm A-M. Vaccines against mucosal infections. Curr Opin Immunol 2012;24:343-53.
22. Ali M, Emch M, von Seidlein L, et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 2005;366:44-9. (Pubitemid 40956529)
23. Ali M, Sur D, You YA, et al. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis 2013;56:1123-31.
24. Khatib AM, Ali M, von Seidlein L, et al. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis 2012;12:837-44.
25. Dorlencourt F, Legros D, Paquet C, Neira M, Ivanoff B, Le Saout E. Effectiveness of mass vaccination with WC/rBS cholera vaccine during an epidemic in Adjumani district, Uganda. Bull World Health Organ 1999;77:949-50.
26. Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis 2007;7:521-30. (Pubitemid 47079151)
27. Page A-L, Alberti KP, Mondonge V, Rauzier J, Quilici M-L, Guerin PJ. Evaluation of a rapid test for the diagnosis of cholera in the absence of a gold standard. PLoS One 2012;7(5):e37360.
28. Martinez-Pino I, Luquero FJ, Sakoba K, et al. Use of a cholera rapid diagnostic test during a mass vaccination campaign in response to an epidemic in Guinea, 2012. PLoS Negl Trop Dis 2013;7(8):e2366.
29. Ahmed ZU, Hoque MM, Rahman AS, Sack RB. Thermal stability of an oral killed-cholera-whole-cell vaccine containing recombinant B-subunit of cholera toxin. Microbiol Immunol 1994;38:837-42. (Pubitemid 24353698)